The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis

Objective. To compare the efficacy in patients with different genotypes, identify the potential predictive factors, and summarize the complications of globus pallidus deep brain stimulation (GPi-DBS) treating early-onset dystonia. Methods. Three electronic databases (PubMed, Embase, and Cochrane dat...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenxiu Chen, Houyou Fan, Guohui Lu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2021/9924639
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546989482442752
author Wenxiu Chen
Houyou Fan
Guohui Lu
author_facet Wenxiu Chen
Houyou Fan
Guohui Lu
author_sort Wenxiu Chen
collection DOAJ
description Objective. To compare the efficacy in patients with different genotypes, identify the potential predictive factors, and summarize the complications of globus pallidus deep brain stimulation (GPi-DBS) treating early-onset dystonia. Methods. Three electronic databases (PubMed, Embase, and Cochrane databases) were searched with no publication data restriction. The primary outcomes were the improvements in Burke–Fahn–Marsden Dystonia Rating Scale motor (BFMDRS-M) and disability (BFMDRS-D) score. Pearson’s correlation coefficients and a metaregression analysis were used to identify the potential predictive factors. This article was registered in Prospero (CRD42020188527). Results. Fifty-four studies (231 patients) were included. Patients showed significant improvement rate in BFMDRS-M (60.6%, p<0.001) and BFMDRS-D (57.5%, p<0.001) scores after treatment with GPi-DBS. BFMDRS-M score improved greater in the DYT-1-positive (p=0.001) and DYT-11-positive (p=0.008) patients compared to DYT-6-positive patients. BFMDRS-D score improved greater in the DYT-11 (+) compared to DYT-6 (+) patients (p=0.010). The relative change of BFMDRS-M (p=0.002) and BFMDRS-D (p=0.010) scores was negatively correlated with preoperative BFMDRS-M score. In the metaregression analysis, the best predictive model showed that preoperative BFMDRS-M, disease duration (p=0.047), and the age at symptom onset (p=0.027) were important. Conclusion. Patients with early-onset dystonia have a significant effect after GPi-DBS treatment, and DYT-1 (+) and DYT-11 (+) patients are better candidates for GPi-DBS. Lower preoperative score, later age of onset, and an earlier age at surgery probably predict better clinical outcomes.
format Article
id doaj-art-0a95042e176141988519975efa52f400
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-0a95042e176141988519975efa52f4002025-02-03T06:46:16ZengWileyNeural Plasticity2090-59041687-54432021-01-01202110.1155/2021/99246399924639The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient AnalysisWenxiu Chen0Houyou Fan1Guohui Lu2Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaObjective. To compare the efficacy in patients with different genotypes, identify the potential predictive factors, and summarize the complications of globus pallidus deep brain stimulation (GPi-DBS) treating early-onset dystonia. Methods. Three electronic databases (PubMed, Embase, and Cochrane databases) were searched with no publication data restriction. The primary outcomes were the improvements in Burke–Fahn–Marsden Dystonia Rating Scale motor (BFMDRS-M) and disability (BFMDRS-D) score. Pearson’s correlation coefficients and a metaregression analysis were used to identify the potential predictive factors. This article was registered in Prospero (CRD42020188527). Results. Fifty-four studies (231 patients) were included. Patients showed significant improvement rate in BFMDRS-M (60.6%, p<0.001) and BFMDRS-D (57.5%, p<0.001) scores after treatment with GPi-DBS. BFMDRS-M score improved greater in the DYT-1-positive (p=0.001) and DYT-11-positive (p=0.008) patients compared to DYT-6-positive patients. BFMDRS-D score improved greater in the DYT-11 (+) compared to DYT-6 (+) patients (p=0.010). The relative change of BFMDRS-M (p=0.002) and BFMDRS-D (p=0.010) scores was negatively correlated with preoperative BFMDRS-M score. In the metaregression analysis, the best predictive model showed that preoperative BFMDRS-M, disease duration (p=0.047), and the age at symptom onset (p=0.027) were important. Conclusion. Patients with early-onset dystonia have a significant effect after GPi-DBS treatment, and DYT-1 (+) and DYT-11 (+) patients are better candidates for GPi-DBS. Lower preoperative score, later age of onset, and an earlier age at surgery probably predict better clinical outcomes.http://dx.doi.org/10.1155/2021/9924639
spellingShingle Wenxiu Chen
Houyou Fan
Guohui Lu
The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
Neural Plasticity
title The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
title_full The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
title_fullStr The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
title_full_unstemmed The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
title_short The Efficacy and Predictors of Using GPi-DBS to Treat Early-Onset Dystonia: An Individual Patient Analysis
title_sort efficacy and predictors of using gpi dbs to treat early onset dystonia an individual patient analysis
url http://dx.doi.org/10.1155/2021/9924639
work_keys_str_mv AT wenxiuchen theefficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis
AT houyoufan theefficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis
AT guohuilu theefficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis
AT wenxiuchen efficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis
AT houyoufan efficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis
AT guohuilu efficacyandpredictorsofusinggpidbstotreatearlyonsetdystoniaanindividualpatientanalysis